| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ars Pharmaceuticals, Inc. (SPRY) has 17 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. SPRY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.89M | $50.39M | - | |
| Dir | 4.47M | $46.13M | - | |
| Other | 240.0K | $2.47M | - | |
| Other | 240.0K | $2.47M | - | |
| CEO | 240.0K | $2.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2020 | Hawkinson Russ | Sr. Vice President Of Finance | Buy | 238 | $21.00 | $4,998.00 | New | |
| Dec 8, 2020 | Piazza Jonathan | Chief Financial Officer | Buy | 11,904 | $21.00 | $249,984.00 | New | |
| Dec 8, 2020 | Capps Vickie L | Director | Buy | 9,523 | $21.00 | $199,983.00 | +18.3% | |
| Dec 8, 2020 | Schroeder Thilo80 | Director | Buy | 238,096 | $21.00 | $5,000,016.00 | New |